Variant report

Variant	esv3486576
Chromosome Location	chr3:139652862-139656260
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:290)
CpG islands
(count:854)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:290 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr3:139654108-139654260	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr3:139654516-139654523	H1-hESC	embryonic stem cell:	n/a	n/a
3	CCNT2	chr3:139654009-139654199	K562	blood:	n/a	n/a
4	CEBPB	chr3:139653423-139653643	H1-hESC	embryonic stem cell:	n/a	n/a
5	CHD2	chr3:139654918-139654933	H1-hESC	embryonic stem cell:	n/a	n/a
6	CHD2	chr3:139653445-139653754	H1-hESC	embryonic stem cell:	n/a	n/a
7	CREB1	chr3:139653808-139654178	A549	lung:	n/a	chr3:139653971-139653984
8	CREB1	chr3:139653000-139654183	H1-hESC	embryonic stem cell:	n/a	chr3:139653971-139653984
9	CREB1	chr3:139653164-139654436	H1-hESC	embryonic stem cell:	n/a	chr3:139653971-139653984
10	CTBP2	chr3:139653274-139655142	H1-hESC	embryonic stem cell:	n/a	n/a
11	CTCF	chr3:139654148-139654158	GM10266	blood:	n/a	n/a
12	CTCF	chr3:139653467-139653612	LNCaP	prostate:	n/a	n/a
13	CTCF	chr3:139654180-139654330	WERI-Rb-1	eye:	n/a	n/a
14	CTCF	chr3:139656040-139656190	AG04450	lung:	n/a	n/a
15	CTCF	chr3:139654300-139654450	GM12869	blood:	n/a	n/a
16	CTCF	chr3:139653192-139654642	SK-N-SH	brain:	n/a	n/a
17	CTCF	chr3:139653500-139653650	AG04449	skin:	n/a	n/a
18	CTCF	chr3:139654304-139654376	GM12891	blood:	n/a	n/a
19	CTCF	chr3:139653460-139653610	HPF	lung:	n/a	n/a
20	CTCF	chr3:139653447-139653659	Pancreas_OC	pancreas:	n/a	n/a
21	CTCF	chr3:139654080-139654230	HCPEpiC	choroid plexus:	n/a	n/a
22	CTCF	chr3:139653500-139653650	AG09319	gingival:	n/a	n/a
23	CTCF	chr3:139653385-139653724	MCF-7	breast:	n/a	n/a
24	CTCF	chr3:139653400-139653550	HCM	heart:	n/a	n/a
25	CTCF	chr3:139654308-139654399	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTCF	chr3:139653420-139653678	NHEK	skin:	n/a	n/a
27	CTCF	chr3:139653440-139653590	HAc	cerebellar:	n/a	n/a
28	CTCF	chr3:139654021-139654431	MCF-7	breast:	n/a	n/a
29	CTCF	chr3:139653460-139653610	HBMEC	blood vessel:	n/a	n/a
30	CTCF	chr3:139653504-139653608	Lung_OC	lung:	n/a	n/a
31	CTCF	chr3:139654180-139654330	HRPEpiC	eye:	n/a	n/a
32	CTCF	chr3:139653400-139653550	HVMF	connective:	n/a	n/a
33	CTCF	chr3:139654156-139654258	Pancreas_OC	pancreas:	n/a	n/a
34	CTCF	chr3:139653460-139653610	HCFaa	heart:	n/a	n/a
35	CTCF	chr3:139654200-139654350	SK-N-SH_RA	brain:	n/a	n/a
36	CTCF	chr3:139654240-139654390	HRPEpiC	eye:	n/a	n/a
37	CTCF	chr3:139653420-139653570	GM12871	blood:	n/a	n/a
38	CTCF	chr3:139654100-139654250	GM12865	blood:	n/a	n/a
39	CTCF	chr3:139653466-139653635	GM19240	blood:	n/a	n/a
40	CTCF	chr3:139654320-139654470	GM12867	blood:	n/a	n/a
41	CTCF	chr3:139653390-139653742	MCF-7	breast:	n/a	n/a
42	CTCF	chr3:139653480-139653630	SK-N-SH_RA	brain:	n/a	n/a
43	CTCF	chr3:139653440-139653590	GM12868	blood:	n/a	n/a
44	CTCF	chr3:139654087-139654357	MCF-7	breast:	n/a	n/a
45	CTCF	chr3:139653377-139653656	HepG2	liver:	n/a	n/a
46	CTCF	chr3:139653410-139653720	H1-hESC	embryonic stem cell:	n/a	n/a
47	CTCF	chr3:139654140-139654290	GM12870	blood:	n/a	n/a
48	CTCF	chr3:139654280-139654430	GM06990	blood:	n/a	n/a
49	CTCF	chr3:139653428-139653655	Kidney_OC	kidney:	n/a	n/a
50	CTCF	chr3:139653500-139653650	GM12872	blood:	n/a	n/a

(count:854 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:139653928-139653978	K562	blood:	n/a
2	chr3:139653328-139653378	AG10803	skin:	n/a
3	chr3:139656251-139656301	HCPEpiC	choroid plexus:	n/a
4	chr3:139654740-139654790	BJ	skin:	n/a
5	chr3:139656251-139656301	PFSK-1	brain:	n/a
6	chr3:139655077-139655127	A549	lung:	n/a
7	chr3:139653915-139653965	SK-N-SH	brain:	n/a
8	chr3:139655283-139655333	NT2-D1	testis:	n/a
9	chr3:139653573-139653623	U87	brain:	n/a
10	chr3:139653915-139653965	HRE	kidney:	n/a
11	chr3:139653431-139653481	HUVEC	blood vessel:	n/a
12	chr3:139653545-139653595	T-47D	breast:	n/a
13	chr3:139655800-139655850	HUVEC	blood vessel:	n/a
14	chr3:139653872-139653922	ovcar-3	ovarian:	n/a
15	chr3:139654740-139654790	HNPCEpiC	eye:	n/a
16	chr3:139654245-139654295	NH-A	brain:	n/a
17	chr3:139653915-139653965	SAEC	small airway:	n/a
18	chr3:139655800-139655850	Caco-2	colon:	n/a
19	chr3:139653545-139653595	AG04449	skin:	fetal
20	chr3:139654740-139654790	IMR90	lung:	fetal
21	chr3:139655077-139655127	MCF-7	breast:	n/a
22	chr3:139654245-139654295	GM12878	blood:	n/a
23	chr3:139655077-139655127	GM12892	blood:	n/a
24	chr3:139653928-139653978	Caco-2	colon:	n/a
25	chr3:139655800-139655850	AoSMC	blood vessel:	n/a
26	chr3:139655077-139655127	HRCEpiC	kidney:	n/a
27	chr3:139653915-139653965	H1-hESC	embryonic stem cell:	embryo
28	chr3:139653872-139653922	AG09319	gingival:	n/a
29	chr3:139655283-139655333	SK-N-SH	brain:	n/a
30	chr3:139653431-139653481	AoSMC	blood vessel:	n/a
31	chr3:139655800-139655850	SK-N-MC	brain:	n/a
32	chr3:139653915-139653965	NB4	blood:	n/a
33	chr3:139653431-139653481	HRCEpiC	kidney:	n/a
34	chr3:139653431-139653481	MCF-7	breast:	n/a
35	chr3:139655077-139655127	HIPEpiC	eye:	n/a
36	chr3:139654245-139654295	PANC-1	pancreas:	n/a
37	chr3:139653928-139653978	H1-hESC	embryonic stem cell:	embryo
38	chr3:139656251-139656301	HCT-116	colon:	n/a
39	chr3:139653573-139653623	IMR90	lung:	fetal
40	chr3:139653915-139653965	AG04449	skin:	fetal
41	chr3:139653573-139653623	BJ	skin:	n/a
42	chr3:139655077-139655127	Jurkat	blood:	n/a
43	chr3:139653872-139653922	A549	lung:	n/a
44	chr3:139654264-139654314	NHBE	bronchial:	n/a
45	chr3:139653915-139653965	AG09309	skin:	n/a
46	chr3:139654264-139654314	Caco-2	colon:	n/a
47	chr3:139655800-139655850	A549	lung:	n/a
48	chr3:139654264-139654314	Jurkat	blood:	n/a
49	chr3:139653928-139653978	PANC-1	pancreas:	n/a
50	chr3:139654245-139654295	AG04449	skin:	fetal

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:139282929..139283874-chr3:139652757..139653752,4	MCF-7	breast:
2	chr3:139347937..139348556-chr3:139653424..139653964,2	MCF-7	breast:
3	chr3:139438799..139439673-chr3:139652877..139653733,2	MCF-7	breast:
4	chr3:139653263..139655437-chr3:139655759..139658179,2	K562	blood:
5	chr3:139437070..139437910-chr3:139653098..139654016,8	MCF-7	breast:
6	chr3:139654619..139655608-chr3:140217733..140218478,2	MCF-7	breast:
7	chr3:139307203..139308238-chr3:139653078..139653999,6	MCF-7	breast:
8	chr3:139656013..139657182-chr3:139769630..139770896,8	MCF-7	breast:
9	chr3:139270922..139271855-chr3:139653137..139653973,3	MCF-7	breast:

No data

Variant related genes	Relation type
CLSTN2	TF binding region
CLSTN2	CpG island
ENSG00000158258	chromatin interactions

Extended variants
information (count: 123 )
Associated
traits (count: 53 )

Variant overlapped rSNPs/rCNVs (count:123 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs189399495	chr3:139652883-139652884	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs80105998	chr3:139652911-139652912	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs576093802	chr3:139652989-139652990	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs545107243	chr3:139653008-139653009	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs148691624	chr3:139653045-139653046	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs56160528	chr3:139653079-139653080	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs9815926	chr3:139653080-139653081	Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
8	rs142219606	chr3:139653094-139653095	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs555380574	chr3:139653120-139653121	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs543433995	chr3:139653128-139653129	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs67101572	chr3:139653137-139653138	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs34516571	chr3:139653139-139653140	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs572015699	chr3:139653236-139653237	Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs540476894	chr3:139653241-139653242	Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs73224940	chr3:139653284-139653285	Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs373359156	chr3:139653331-139653332	Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs565785562	chr3:139653353-139653354	Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs369248788	chr3:139653361-139653362	Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
19	rs528281786	chr3:139653363-139653364	Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs548366724	chr3:139653375-139653376	Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs568166179	chr3:139653388-139653389	Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs537118246	chr3:139653393-139653394	Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs557014127	chr3:139653422-139653423	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs570401910	chr3:139653434-139653435	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs539008448	chr3:139653444-139653445	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
26	rs559192638	chr3:139653490-139653491	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs115466320	chr3:139653531-139653532	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs541227700	chr3:139653563-139653564	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs543927732	chr3:139653617-139653618	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs574607340	chr3:139653626-139653627	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs139287628	chr3:139653671-139653672	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs542846224	chr3:139653711-139653712	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs34705801	chr3:139653725-139653726	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs144058354	chr3:139653743-139653744	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs532536014	chr3:139653755-139653756	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs545821028	chr3:139653785-139653786	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs559609442	chr3:139653793-139653794	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs528330062	chr3:139653817-139653818	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs548429967	chr3:139653914-139653915	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs34435091	chr3:139653928-139653929	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs146460085	chr3:139653972-139653973	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs563873565	chr3:139653998-139653999	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs530647525	chr3:139654015-139654016	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs550689526	chr3:139654020-139654021	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs570391029	chr3:139654197-139654198	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs539426386	chr3:139654245-139654246	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs552647225	chr3:139654275-139654276	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs566383695	chr3:139654280-139654281	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs74884664	chr3:139654298-139654299	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs554776795	chr3:139654318-139654319	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:53)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Cervical cancer	21062161	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Bipolar disorder	18458673	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
microdeletion syndrome	22180640	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Multiple myeloma	17550852	CNVD
Basal cell lymphoma	21115979	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	18645599	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Hepatocellular carcinoma	16750200	CNVD
Lung cancer	16740712	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
Blepharophimosis-ptosis-epicanthus inversus syndrome	22067867	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelofibrosis	22110671	CNVD
abnormal development	18461090	CNVD
Congenital anomalies of the kidney and urinary tract	20605837	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:379 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:139649600-139653400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
2	chr3:139651800-139653200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
3	chr3:139651800-139653200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
4	chr3:139653200-139653400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr3:139653200-139653400	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
6	chr3:139653200-139653400	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
7	chr3:139653200-139653400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
8	chr3:139653200-139653400	Bivalent Enhancer	Adipose Nuclei	Adipose
9	chr3:139653200-139653400	Enhancers	Brain Angular Gyrus	brain
10	chr3:139653200-139653400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
11	chr3:139653200-139653400	Enhancers	Ovary	ovary
12	chr3:139653200-139653400	Enhancers	Pancreas	Pancrea
13	chr3:139653200-139653400	Enhancers	Skeletal Muscle Female	skeletal muscle
14	chr3:139653200-139653400	Flanking Bivalent TSS/Enh	HSMMtube	muscle
15	chr3:139653200-139653600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
16	chr3:139653200-139653600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr3:139653200-139653600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
18	chr3:139653200-139653600	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr3:139653200-139653600	Bivalent Enhancer	Fetal Intestine Small	intestine
20	chr3:139653200-139653600	Bivalent Enhancer	Placenta	Placenta
21	chr3:139653200-139654000	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
22	chr3:139653200-139654200	Enhancers	Fetal Brain Male	brain
23	chr3:139653200-139654800	Active TSS	Brain Anterior Caudate	brain
24	chr3:139653200-139655000	Active TSS	Brain Cingulate Gyrus	brain
25	chr3:139653200-139655200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
26	chr3:139653200-139655200	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
27	chr3:139653200-139655200	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
28	chr3:139653200-139655400	Active TSS	Pancreatic Islets	Pancreatic Islet
29	chr3:139653200-139655600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
30	chr3:139653200-139655600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
31	chr3:139653200-139656000	Active TSS	Brain Inferior Temporal Lobe	brain
32	chr3:139653400-139653600	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
33	chr3:139653400-139653600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
34	chr3:139653400-139653600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
35	chr3:139653400-139653600	Bivalent Enhancer	Duodenum Mucosa	Duodenum
36	chr3:139653400-139653600	Bivalent Enhancer	Fetal Intestine Large	intestine
37	chr3:139653400-139653600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
38	chr3:139653400-139653600	Flanking Active TSS	Ovary	ovary
39	chr3:139653400-139653600	Active TSS	Psoas Muscle	Psoas
40	chr3:139653400-139653600	Enhancers	Right Atrium	heart
41	chr3:139653400-139653600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
42	chr3:139653400-139653800	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
43	chr3:139653400-139653800	Flanking Active TSS	Primary hematopoietic stem cells	blood
44	chr3:139653400-139653800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr3:139653400-139653800	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr3:139653400-139653800	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose
47	chr3:139653400-139653800	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
48	chr3:139653400-139653800	Bivalent/Poised TSS	Colon Smooth Muscle	Colon
49	chr3:139653400-139653800	Flanking Bivalent TSS/Enh	Duodenum Smooth Muscle	Duodenum
50	chr3:139653400-139653800	Flanking Bivalent TSS/Enh	Fetal Stomach	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links